PMC:7441788 / 17858-18050
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T102","span":{"begin":113,"end":121},"obj":"Disease"}],"attributes":[{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T181","span":{"begin":160,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T229","span":{"begin":178,"end":183},"obj":"Chemical"}],"attributes":[{"id":"A229","pred":"chebi_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-sample-PD-NCBITaxon
{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T104","span":{"begin":113,"end":121},"obj":"Species"}],"attributes":[{"id":"A104","pred":"ncbi_taxonomy_id","subj":"T104","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T134","span":{"begin":123,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"644","span":{"begin":82,"end":90},"obj":"Species"},{"id":"673","span":{"begin":22,"end":25},"obj":"Chemical"},{"id":"711","span":{"begin":113,"end":121},"obj":"Disease"}],"attributes":[{"id":"A644","pred":"pubann:denotes","subj":"644","obj":"Tax:9606"},{"id":"A673","pred":"pubann:denotes","subj":"673","obj":"MESH:D006886"},{"id":"A711","pred":"pubann:denotes","subj":"711","obj":"MESH:C000657245"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T119","span":{"begin":13,"end":20},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-sample-PD-MONDO
{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T95","span":{"begin":113,"end":121},"obj":"Disease"}],"attributes":[{"id":"A95","pred":"mondo_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"644","span":{"begin":82,"end":90},"obj":"Species"},{"id":"673","span":{"begin":22,"end":25},"obj":"Chemical"},{"id":"711","span":{"begin":113,"end":121},"obj":"Disease"}],"attributes":[{"id":"A644","pred":"tao:has_database_id","subj":"644","obj":"Tax:9606"},{"id":"A673","pred":"tao:has_database_id","subj":"673","obj":"MESH:D006886"},{"id":"A711","pred":"tao:has_database_id","subj":"711","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T134","span":{"begin":123,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. Randomized controlled study. Lack of a placebo control group; Design "}